title: Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution.
authors.affiliation: Alliance Pharmaceutical Corp., San Diego, CA.
authors.forename: P E
authors.initials: PE
authors.lastname: Keipert
authors.forename: N S
authors.initials: NS
authors.lastname: Faithfull
authors.forename: J D
authors.initials: JD
authors.lastname: Bradley
authors.forename: D Y
authors.initials: DY
authors.lastname: Hazard
authors.forename: J
authors.initials: J
authors.lastname: Hogan
authors.forename: M S
authors.initials: MS
authors.lastname: Levisetti
authors.forename: R M
authors.initials: RM
authors.lastname: Peters
mesh_terms: D000818:Animals; D001802:Blood Substitutes / Q000008:administration & dosage*; D001804:Blood Transfusion, Autologous; D001809:Blood Viscosity / Q000187:drug effects; D001810:Blood Volume; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004655:Emulsions; D005466:Fluorocarbons / Q000008:administration & dosage*; D006400:Hematocrit; D006438:Hemodilution; D006842:Hydrocarbons, Brominated; D007262:Infusions, Intravenous; D007430:Intraoperative Care; D010100:Oxygen / Q000097:blood*; D010101:Oxygen Consumption / Q000187:drug effects
chemical_list: D001802:Blood Substitutes; D004655:Emulsions; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; C003072:perflubron; D010100:Oxygen